94,99 €
94,99 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
94,99 €
Als Download kaufen
94,99 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
94,99 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
0 °P sammeln
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Comprehensive textbook on molecular pathology for newcomers to the field, covering history, analytics, types of cancers, and more
Molecular Pathology delivers an in-depth outline of molecular pathology appropriate for the undergraduate, postgraduate, or early-stage career lab scientist, drawing from authoritative sources such as NICE, the World Health Organisation, the Office of National Statistics, clinical guidelines, research publications and the National Genomic Test Directory. The text contains numerous tables, diagrams, and photos in each chapter to help elucidate key…mehr
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 5.88MB
Andere Kunden interessierten sich auch für
- Andrew BlannMolecular Pathology (eBook, ePUB)94,99 €
- Biomaterials and Neurodegenerative Disorders (eBook, PDF)137,95 €
- Noninvasive Molecular Markers in Gynecologic Cancers (eBook, PDF)69,95 €
- Brendan CurranA Terrible Beauty is Born (eBook, PDF)31,95 €
- Agricultural Biotechnology (eBook, PDF)67,95 €
- Bioinformatics and Human Genomics Research (eBook, PDF)69,95 €
- Kewal K. JainThe Handbook of Nanomedicine (eBook, PDF)81,95 €
-
-
-
Comprehensive textbook on molecular pathology for newcomers to the field, covering history, analytics, types of cancers, and more
Molecular Pathology delivers an in-depth outline of molecular pathology appropriate for the undergraduate, postgraduate, or early-stage career lab scientist, drawing from authoritative sources such as NICE, the World Health Organisation, the Office of National Statistics, clinical guidelines, research publications and the National Genomic Test Directory. The text contains numerous tables, diagrams, and photos in each chapter to help elucidate key concepts.
The opening chapter provides a general introduction to the subject with a historical perspective of key findings that have led to our current view of molecular pathology. The introduction is followed by a look at the scope of chromosomal disease (such as Down's syndrome) and genetic disease (such as sickle cell disease). Chapter two describes the numerous analytical tools required in molecular pathology, and how complex genetic data is interpreted - i.e., bioinformatics. The remaining three chapters review the molecular pathology of focused groups of disease, including solid tumor cancer, blood cancer, and metabolic and other genetic diseases. Each of these three chapters explains the role of molecular pathology in the etiology, diagnosis, and management of each particular condition.
Sample topics explored in Molecular Pathology include:
Molecular Pathology serves as an excellent introduction to the subject for first to third year undergraduate students. Healthcare professionals and biomedical scientists and researchers will also find it valuable.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Molecular Pathology delivers an in-depth outline of molecular pathology appropriate for the undergraduate, postgraduate, or early-stage career lab scientist, drawing from authoritative sources such as NICE, the World Health Organisation, the Office of National Statistics, clinical guidelines, research publications and the National Genomic Test Directory. The text contains numerous tables, diagrams, and photos in each chapter to help elucidate key concepts.
The opening chapter provides a general introduction to the subject with a historical perspective of key findings that have led to our current view of molecular pathology. The introduction is followed by a look at the scope of chromosomal disease (such as Down's syndrome) and genetic disease (such as sickle cell disease). Chapter two describes the numerous analytical tools required in molecular pathology, and how complex genetic data is interpreted - i.e., bioinformatics. The remaining three chapters review the molecular pathology of focused groups of disease, including solid tumor cancer, blood cancer, and metabolic and other genetic diseases. Each of these three chapters explains the role of molecular pathology in the etiology, diagnosis, and management of each particular condition.
Sample topics explored in Molecular Pathology include:
- Generating DNA and RNA for analysis, amplification by PCR, and DNA sequencing through micro-arrays, libraries, and Next Generation Sequencing
- Chromosome structure, covering histones and the centromere, abnormal chromosome numbers, and errors within chromosomes such as translocations and deletions
- Myelofibrosis, myelodysplasia, essential thrombocythemia, polycythaemia, leukemia, lymphoma, myeloma, and haemopoiesis and maturation arrest
- Molecular pathology of single organ/organ system disease, such as Huntington's and cardiomyopathy, and multi-organ disease such as Barth syndrome
Molecular Pathology serves as an excellent introduction to the subject for first to third year undergraduate students. Healthcare professionals and biomedical scientists and researchers will also find it valuable.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in D ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Wiley
- Seitenzahl: 381
- Erscheinungstermin: 18. April 2025
- Englisch
- ISBN-13: 9781394254651
- Artikelnr.: 73923293
- Verlag: Wiley
- Seitenzahl: 381
- Erscheinungstermin: 18. April 2025
- Englisch
- ISBN-13: 9781394254651
- Artikelnr.: 73923293
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Andrew Blann is Visiting Reader in Biomedical Science at Huddersfield University, UK and Chair of the Molecular Pathology Advisory Panel at the Institute of Biomedical Science in London, UK, a leading group that speaks for 20,000 laboratory scientists. He has six textbooks in press on clinical and biomedical science and has over 500 published research articles available on PubMed. He was Editor of the British Journal of Biomedical Science from 2015-2021, currently Assistant Chief Editor from 2021 to the present.
Preface xiii
Acknowledgements xvii
1 Introduction to Molecular Pathology 1
1.1 A Historical Perspective 2
1.1.1 The Development of Molecular Genetics 2
1.1.2 The Development of Molecular Pathology 8
1.2 The Scope of Human Disease 15
1.2.1 The Classification of Disease 15
1.2.2 Morbidity and Mortality 17
1.3 Chromosomal Abnormalities and Disease 19
1.3.1 Chromosomes in Health and Disease 19
1.3.2 Errors of Chromosome Numbers 24
1.3.3 Errors of Sections of Chromosomes 26
1.3.4 Micro-changes to the Genome 32
1.4 The Practice of Molecular Pathology 34
1.4.1 Personalised Medicine 35
1.4.2 National Developments in Molecular Pathology 36
1.4.3 A Move Back to the General Hospital 38
1.5 Conclusion and a View Forwards 39
2 Methods in Molecular Pathology 1 45
2.1 Sample Acquisition and Preparation 46
2.1.1 General Considerations 46
2.1.2 Blood and Soft Tissue 47
2.1.3 Tissues from Solid Organs 48
2.2 Cytogenetics and Karyotyping 49
2.2.1 Practical Considerations 49
2.2.2 Historical Perspective 50
2.2.3 Modern Clinical Applications 52
2.2.4 Paediatrics and Cytogenetics 54
2.3 Fluorescence In situ Hybridisation 54
2.3.1 The Evolution of FISH 55
2.3.2 Uses of FISH Variants in Pathology 56
2.3.3 Developments in FISH 61
2.4 Preparation of Nucleic Acids for Analysis 62
2.4.1 Obtaining DNA 62
2.4.2 Obtaining RNA 63
2.4.3 The Library 65
2.4.4 Amplification of DNA: The Polymerase Chain Reaction 66
2.4.5 Developments in PCR 68
2.5 DNA Sequencing 75
2.5.1 Sanger Sequencing 76
2.5.2 Technical Advances 77
2.5.3 The Human Genome Project 78
2.6 Microarrays 78
2.6.1 The Theory 78
2.6.2 The Practice 80
2.6.3 Disease-linked Gene Panels 83
2.7 Summary of First-generation Techniques 84
2.7.1 Moving On 85
3 Methods in Molecular Pathology 2 87
3.1 Next-generation Sequencing 88
3.1.1 Read Length 88
3.1.2 Pyrosequencing 89
3.1.3 Ion Torrent Technology 92
3.1.4 Illumina Sequencing 94
3.1.5 SOLiD Technology 97
3.1.6 Luminex Multi-analyte Profiling (xMAP) technology 99
3.1.7 RNA Sequencing 100
3.1.8 Wider Applications of Next-generation Sequencing 100
3.1.9 Global and Other Perspectives 104
3.2 Third-generation Sequencing 107
3.2.1 Nanopore Sequencing 108
3.2.2 Pacific Biosystems 110
3.2.3 DNA Nanoball Technology 112
3.3 Bioinformatics 114
3.4 Chapter Summary and Conclusions 115
3.4.1 The Technology 115
3.4.2 The Practice of Molecular Pathology 115
4 Solid Tumour Cancer 1: Carcinoma 119
4.1 Introduction to Cancer 120
4.1.1 General Comments 120
4.1.2 Classification of Cancer 121
4.1.3 The Incidence and Mortality of Malignant Cancer 123
4.2 The Cellular Basis of Cancer 125
4.2.1 Carcinogenesis 125
4.2.2 Genes, Proto-oncogenes and Oncogenes 125
4.2.3 Genes and Cancer 127
4.2.4 Developing Initiatives in Cancer Genetics 130
4.2.5 Summary of Section 4.2 132
4.3 Lung Cancer 133
4.3.1 Introduction 133
4.3.2 Molecular Pathology 134
4.3.3 Which Genes to Test? 136
4.3.4 Molecular Pathology Directing Treatment 138
4.4 Colorectal Cancer 140
4.4.1 Introduction 140
4.4.2 Molecular Pathology 141
4.4.3 Which Genes to Test? 143
4.4.4 Molecular Pathology Directing Treatment 143
4.5 Prostate Cancer 144
4.5.1 Introduction 144
4.5.2 Molecular Pathology 145
4.5.3 Which Genes to Test? 146
4.5.4 Molecular Pathology Directing Treatment 146
4.6 Breast Cancer 147
4.6.1 Introduction 147
4.6.2 Molecular Pathology 148
4.6.3 Which Genes to Test? 149
4.6.4 Molecular Pathology Directing Treatment 151
4.7 Pancreatic Cancer 154
4.7.1 Introduction 154
4.7.2 Molecular Pathology 154
4.7.3 Which Genes to Test? 155
4.7.4 Molecular Pathology Directing Treatment 156
4.8 Other Carcinomas 156
4.8.1 Oesophageal Cancer 156
4.8.2 Liver Cancer 156
4.8.3 Bladder Cancer 157
4.8.4 Renal Cancer 157
4.8.5 Ovarian Cancer 158
4.8.6 Rare Carcinomas 159
4.9 Chapter Summary 161
4.9.1 Ntrk 162
4.9.2 Brca 162
4.9.3 Panels of Genes 164
4.9.4 Bridge to Chapter 5 165
5 Solid Organ Cancers Part 2: Sarcoma, Neurological, Paediatric, Dermal and
Others 167
5.1 Sarcomas 168
5.1.1 Tumours Based on Bone 168
5.1.2 Tumours Based on Muscle and Soft Tissues 169
5.2 Tumours of the Central Nervous System 174
5.2.1 Gliomas 174
5.2.2 Meningiomas 177
5.2.3 Medulloblastomas 177
5.2.4 Pituitary Tumours 178
5.3 Paediatric Cancers 178
5.3.1 Introduction to Paediatrics 178
5.3.2 Blood Cancer 182
5.3.3 Neurological Tumours 186
5.3.4 Solid Organ Cancers 190
5.4 Dermal Cancers 194
5.4.1 Squamous Cell Carcinoma and Basal Cell Carcinoma 194
5.4.2 Melanoma 194
5.4.3 Dermatofibrosarcoma Protuberans 195
5.5 Other Cancers 196
5.5.1 Multiple Endocrine Neoplasia 196
5.5.2 Inherited Cancers 197
5.6 Summary 198
6 Blood Cancer 201
6.1 Lymphoma 202
6.1.1 Hodgkin Lymphoma 203
6.1.2 Non-Hodgkin Lymphoma 205
6.2 Leukaemia 211
6.2.1 The Aetiology of Leukaemia 212
6.2.2 Myeloid Leukaemia 213
6.2.3 Lymphoid Leukaemia 221
6.2.4 Other Types of Leukaemia 228
6.2.5 Measurable Residual Disease 232
6.3 Myeloma and Related Diseases 233
6.3.1 The Laboratory 233
6.3.2 Monoclonal Gammopathy of Undetermined Significance 234
6.3.3 Smouldering Multiple Myeloma 235
6.3.4 Myeloma 237
6.3.5 Plasma Cell Leukaemia 240
6.3.6 The Genetics of Disease Progression 241
6.3.7 Routine Molecular Pathology 241
6.4 Other Blood Cancer 242
6.4.1 Myelofibrosis 243
6.4.2 Polycythaemia Vera 244
6.4.3 Essential Thrombocythaemia 245
6.4.4 Myelodysplasia 246
6.4.5 Routine Molecular Pathology of MPNs 247
6.4.6 Erythroleukaemia 249
6.4.7 Basophils and Mast Cells 250
6.4.8 Histiocytosis 252
6.5 Summary 253
7 Rare, Inherited, Metabolic and Other Diseases 257
7.1 Cardiology 259
7.1.1 Structural Heart Disease 260
7.1.2 Arrhythmia 262
7.2 Developmental Disorders 264
7.3 Endocrinology 266
7.3.1 Diabetes 266
7.3.2 Thyroid 267
7.3.3 Adrenals 268
7.3.4 Parathyroids 269
7.3.5 Reproduction 270
7.3.6 The Pituitary/Hypothalamus 272
7.4 Ophthalmology and Audiology 273
7.4.1 Cataracts 273
7.4.2 Albinism 274
7.4.3 The Optic Nerve 275
7.4.4 Other Ocular Diseases 275
7.4.5 Audiology 276
7.5 Foetal and Non-invasive Prenatal Detection 277
7.5.1 The Foetus and Neonate 277
7.5.2 The Parent and Adult 278
7.6 Gastrohepatology 281
7.6.1 Porphyria 281
7.6.2 Cholestasis 281
7.6.3 Polycystic Liver Diseases 281
7.6.4 Pancreatitis 282
7.6.5 Hirschsprung Disease 282
7.7 Haematology 282
7.7.1 Haemoglobinopathies 283
7.7.2 Red Cell Enzymopathies 288
7.7.3 Combined Haemoglobinopathies and Enzymopathies 289
7.7.4 The Red Cell Membrane 290
7.7.5 Other Forms of Anaemia 290
7.7.6 Haemorrhagic Diseases 292
7.7.7 Thrombotic Diseases 295
7.7.8 Iron Metabolism 297
7.8 Immunology 298
7.8.1 Severe Combined Immunodeficiency 298
7.8.2 The Haemophagocytic Syndromes 298
7.8.3 Hereditary Angioedema 298
7.8.4 Other Immunological Diseases 299
7.9 Lipid and Metabolic Diseases 299
7.9.1 Lipids 299
7.9.2 Metabolic Diseases 300
7.10 Mitochondrial Diseases 305
7.11 Musculoskeletal Diseases 307
7.11.1 Diseases Linked to the Fibroblast Growth Factor Receptor 307
7.11.2 Muscular Dystrophy 308
7.11.3 Other Genetic Musculoskeletal Diseases 308
7.12 Neurological Diseases 309
7.12.1 Diseases of the Nerves 310
7.12.2 The Central Nervous System 311
7.12.3 Myopathy 313
7.13 Renal Diseases 314
7.13.1 The Leading Causes 314
7.13.2 Diseases Linked to Electrolyte Disturbances 315
7.13.3 Other Causes 316
7.14 Respiratory Diseases 316
7.14.1 Cystic Fibrosis 316
7.14.2 Other Respiratory Diseases 317
7.15 Dermatological Diseases 318
7.15.1 Xeroderma Pigmentosum 318
7.15.2 Other Dermatological Diseases 319
7.16 Summary 320
Genes Index 323
Text Index 345
Acknowledgements xvii
1 Introduction to Molecular Pathology 1
1.1 A Historical Perspective 2
1.1.1 The Development of Molecular Genetics 2
1.1.2 The Development of Molecular Pathology 8
1.2 The Scope of Human Disease 15
1.2.1 The Classification of Disease 15
1.2.2 Morbidity and Mortality 17
1.3 Chromosomal Abnormalities and Disease 19
1.3.1 Chromosomes in Health and Disease 19
1.3.2 Errors of Chromosome Numbers 24
1.3.3 Errors of Sections of Chromosomes 26
1.3.4 Micro-changes to the Genome 32
1.4 The Practice of Molecular Pathology 34
1.4.1 Personalised Medicine 35
1.4.2 National Developments in Molecular Pathology 36
1.4.3 A Move Back to the General Hospital 38
1.5 Conclusion and a View Forwards 39
2 Methods in Molecular Pathology 1 45
2.1 Sample Acquisition and Preparation 46
2.1.1 General Considerations 46
2.1.2 Blood and Soft Tissue 47
2.1.3 Tissues from Solid Organs 48
2.2 Cytogenetics and Karyotyping 49
2.2.1 Practical Considerations 49
2.2.2 Historical Perspective 50
2.2.3 Modern Clinical Applications 52
2.2.4 Paediatrics and Cytogenetics 54
2.3 Fluorescence In situ Hybridisation 54
2.3.1 The Evolution of FISH 55
2.3.2 Uses of FISH Variants in Pathology 56
2.3.3 Developments in FISH 61
2.4 Preparation of Nucleic Acids for Analysis 62
2.4.1 Obtaining DNA 62
2.4.2 Obtaining RNA 63
2.4.3 The Library 65
2.4.4 Amplification of DNA: The Polymerase Chain Reaction 66
2.4.5 Developments in PCR 68
2.5 DNA Sequencing 75
2.5.1 Sanger Sequencing 76
2.5.2 Technical Advances 77
2.5.3 The Human Genome Project 78
2.6 Microarrays 78
2.6.1 The Theory 78
2.6.2 The Practice 80
2.6.3 Disease-linked Gene Panels 83
2.7 Summary of First-generation Techniques 84
2.7.1 Moving On 85
3 Methods in Molecular Pathology 2 87
3.1 Next-generation Sequencing 88
3.1.1 Read Length 88
3.1.2 Pyrosequencing 89
3.1.3 Ion Torrent Technology 92
3.1.4 Illumina Sequencing 94
3.1.5 SOLiD Technology 97
3.1.6 Luminex Multi-analyte Profiling (xMAP) technology 99
3.1.7 RNA Sequencing 100
3.1.8 Wider Applications of Next-generation Sequencing 100
3.1.9 Global and Other Perspectives 104
3.2 Third-generation Sequencing 107
3.2.1 Nanopore Sequencing 108
3.2.2 Pacific Biosystems 110
3.2.3 DNA Nanoball Technology 112
3.3 Bioinformatics 114
3.4 Chapter Summary and Conclusions 115
3.4.1 The Technology 115
3.4.2 The Practice of Molecular Pathology 115
4 Solid Tumour Cancer 1: Carcinoma 119
4.1 Introduction to Cancer 120
4.1.1 General Comments 120
4.1.2 Classification of Cancer 121
4.1.3 The Incidence and Mortality of Malignant Cancer 123
4.2 The Cellular Basis of Cancer 125
4.2.1 Carcinogenesis 125
4.2.2 Genes, Proto-oncogenes and Oncogenes 125
4.2.3 Genes and Cancer 127
4.2.4 Developing Initiatives in Cancer Genetics 130
4.2.5 Summary of Section 4.2 132
4.3 Lung Cancer 133
4.3.1 Introduction 133
4.3.2 Molecular Pathology 134
4.3.3 Which Genes to Test? 136
4.3.4 Molecular Pathology Directing Treatment 138
4.4 Colorectal Cancer 140
4.4.1 Introduction 140
4.4.2 Molecular Pathology 141
4.4.3 Which Genes to Test? 143
4.4.4 Molecular Pathology Directing Treatment 143
4.5 Prostate Cancer 144
4.5.1 Introduction 144
4.5.2 Molecular Pathology 145
4.5.3 Which Genes to Test? 146
4.5.4 Molecular Pathology Directing Treatment 146
4.6 Breast Cancer 147
4.6.1 Introduction 147
4.6.2 Molecular Pathology 148
4.6.3 Which Genes to Test? 149
4.6.4 Molecular Pathology Directing Treatment 151
4.7 Pancreatic Cancer 154
4.7.1 Introduction 154
4.7.2 Molecular Pathology 154
4.7.3 Which Genes to Test? 155
4.7.4 Molecular Pathology Directing Treatment 156
4.8 Other Carcinomas 156
4.8.1 Oesophageal Cancer 156
4.8.2 Liver Cancer 156
4.8.3 Bladder Cancer 157
4.8.4 Renal Cancer 157
4.8.5 Ovarian Cancer 158
4.8.6 Rare Carcinomas 159
4.9 Chapter Summary 161
4.9.1 Ntrk 162
4.9.2 Brca 162
4.9.3 Panels of Genes 164
4.9.4 Bridge to Chapter 5 165
5 Solid Organ Cancers Part 2: Sarcoma, Neurological, Paediatric, Dermal and
Others 167
5.1 Sarcomas 168
5.1.1 Tumours Based on Bone 168
5.1.2 Tumours Based on Muscle and Soft Tissues 169
5.2 Tumours of the Central Nervous System 174
5.2.1 Gliomas 174
5.2.2 Meningiomas 177
5.2.3 Medulloblastomas 177
5.2.4 Pituitary Tumours 178
5.3 Paediatric Cancers 178
5.3.1 Introduction to Paediatrics 178
5.3.2 Blood Cancer 182
5.3.3 Neurological Tumours 186
5.3.4 Solid Organ Cancers 190
5.4 Dermal Cancers 194
5.4.1 Squamous Cell Carcinoma and Basal Cell Carcinoma 194
5.4.2 Melanoma 194
5.4.3 Dermatofibrosarcoma Protuberans 195
5.5 Other Cancers 196
5.5.1 Multiple Endocrine Neoplasia 196
5.5.2 Inherited Cancers 197
5.6 Summary 198
6 Blood Cancer 201
6.1 Lymphoma 202
6.1.1 Hodgkin Lymphoma 203
6.1.2 Non-Hodgkin Lymphoma 205
6.2 Leukaemia 211
6.2.1 The Aetiology of Leukaemia 212
6.2.2 Myeloid Leukaemia 213
6.2.3 Lymphoid Leukaemia 221
6.2.4 Other Types of Leukaemia 228
6.2.5 Measurable Residual Disease 232
6.3 Myeloma and Related Diseases 233
6.3.1 The Laboratory 233
6.3.2 Monoclonal Gammopathy of Undetermined Significance 234
6.3.3 Smouldering Multiple Myeloma 235
6.3.4 Myeloma 237
6.3.5 Plasma Cell Leukaemia 240
6.3.6 The Genetics of Disease Progression 241
6.3.7 Routine Molecular Pathology 241
6.4 Other Blood Cancer 242
6.4.1 Myelofibrosis 243
6.4.2 Polycythaemia Vera 244
6.4.3 Essential Thrombocythaemia 245
6.4.4 Myelodysplasia 246
6.4.5 Routine Molecular Pathology of MPNs 247
6.4.6 Erythroleukaemia 249
6.4.7 Basophils and Mast Cells 250
6.4.8 Histiocytosis 252
6.5 Summary 253
7 Rare, Inherited, Metabolic and Other Diseases 257
7.1 Cardiology 259
7.1.1 Structural Heart Disease 260
7.1.2 Arrhythmia 262
7.2 Developmental Disorders 264
7.3 Endocrinology 266
7.3.1 Diabetes 266
7.3.2 Thyroid 267
7.3.3 Adrenals 268
7.3.4 Parathyroids 269
7.3.5 Reproduction 270
7.3.6 The Pituitary/Hypothalamus 272
7.4 Ophthalmology and Audiology 273
7.4.1 Cataracts 273
7.4.2 Albinism 274
7.4.3 The Optic Nerve 275
7.4.4 Other Ocular Diseases 275
7.4.5 Audiology 276
7.5 Foetal and Non-invasive Prenatal Detection 277
7.5.1 The Foetus and Neonate 277
7.5.2 The Parent and Adult 278
7.6 Gastrohepatology 281
7.6.1 Porphyria 281
7.6.2 Cholestasis 281
7.6.3 Polycystic Liver Diseases 281
7.6.4 Pancreatitis 282
7.6.5 Hirschsprung Disease 282
7.7 Haematology 282
7.7.1 Haemoglobinopathies 283
7.7.2 Red Cell Enzymopathies 288
7.7.3 Combined Haemoglobinopathies and Enzymopathies 289
7.7.4 The Red Cell Membrane 290
7.7.5 Other Forms of Anaemia 290
7.7.6 Haemorrhagic Diseases 292
7.7.7 Thrombotic Diseases 295
7.7.8 Iron Metabolism 297
7.8 Immunology 298
7.8.1 Severe Combined Immunodeficiency 298
7.8.2 The Haemophagocytic Syndromes 298
7.8.3 Hereditary Angioedema 298
7.8.4 Other Immunological Diseases 299
7.9 Lipid and Metabolic Diseases 299
7.9.1 Lipids 299
7.9.2 Metabolic Diseases 300
7.10 Mitochondrial Diseases 305
7.11 Musculoskeletal Diseases 307
7.11.1 Diseases Linked to the Fibroblast Growth Factor Receptor 307
7.11.2 Muscular Dystrophy 308
7.11.3 Other Genetic Musculoskeletal Diseases 308
7.12 Neurological Diseases 309
7.12.1 Diseases of the Nerves 310
7.12.2 The Central Nervous System 311
7.12.3 Myopathy 313
7.13 Renal Diseases 314
7.13.1 The Leading Causes 314
7.13.2 Diseases Linked to Electrolyte Disturbances 315
7.13.3 Other Causes 316
7.14 Respiratory Diseases 316
7.14.1 Cystic Fibrosis 316
7.14.2 Other Respiratory Diseases 317
7.15 Dermatological Diseases 318
7.15.1 Xeroderma Pigmentosum 318
7.15.2 Other Dermatological Diseases 319
7.16 Summary 320
Genes Index 323
Text Index 345
Preface xiii
Acknowledgements xvii
1 Introduction to Molecular Pathology 1
1.1 A Historical Perspective 2
1.1.1 The Development of Molecular Genetics 2
1.1.2 The Development of Molecular Pathology 8
1.2 The Scope of Human Disease 15
1.2.1 The Classification of Disease 15
1.2.2 Morbidity and Mortality 17
1.3 Chromosomal Abnormalities and Disease 19
1.3.1 Chromosomes in Health and Disease 19
1.3.2 Errors of Chromosome Numbers 24
1.3.3 Errors of Sections of Chromosomes 26
1.3.4 Micro-changes to the Genome 32
1.4 The Practice of Molecular Pathology 34
1.4.1 Personalised Medicine 35
1.4.2 National Developments in Molecular Pathology 36
1.4.3 A Move Back to the General Hospital 38
1.5 Conclusion and a View Forwards 39
2 Methods in Molecular Pathology 1 45
2.1 Sample Acquisition and Preparation 46
2.1.1 General Considerations 46
2.1.2 Blood and Soft Tissue 47
2.1.3 Tissues from Solid Organs 48
2.2 Cytogenetics and Karyotyping 49
2.2.1 Practical Considerations 49
2.2.2 Historical Perspective 50
2.2.3 Modern Clinical Applications 52
2.2.4 Paediatrics and Cytogenetics 54
2.3 Fluorescence In situ Hybridisation 54
2.3.1 The Evolution of FISH 55
2.3.2 Uses of FISH Variants in Pathology 56
2.3.3 Developments in FISH 61
2.4 Preparation of Nucleic Acids for Analysis 62
2.4.1 Obtaining DNA 62
2.4.2 Obtaining RNA 63
2.4.3 The Library 65
2.4.4 Amplification of DNA: The Polymerase Chain Reaction 66
2.4.5 Developments in PCR 68
2.5 DNA Sequencing 75
2.5.1 Sanger Sequencing 76
2.5.2 Technical Advances 77
2.5.3 The Human Genome Project 78
2.6 Microarrays 78
2.6.1 The Theory 78
2.6.2 The Practice 80
2.6.3 Disease-linked Gene Panels 83
2.7 Summary of First-generation Techniques 84
2.7.1 Moving On 85
3 Methods in Molecular Pathology 2 87
3.1 Next-generation Sequencing 88
3.1.1 Read Length 88
3.1.2 Pyrosequencing 89
3.1.3 Ion Torrent Technology 92
3.1.4 Illumina Sequencing 94
3.1.5 SOLiD Technology 97
3.1.6 Luminex Multi-analyte Profiling (xMAP) technology 99
3.1.7 RNA Sequencing 100
3.1.8 Wider Applications of Next-generation Sequencing 100
3.1.9 Global and Other Perspectives 104
3.2 Third-generation Sequencing 107
3.2.1 Nanopore Sequencing 108
3.2.2 Pacific Biosystems 110
3.2.3 DNA Nanoball Technology 112
3.3 Bioinformatics 114
3.4 Chapter Summary and Conclusions 115
3.4.1 The Technology 115
3.4.2 The Practice of Molecular Pathology 115
4 Solid Tumour Cancer 1: Carcinoma 119
4.1 Introduction to Cancer 120
4.1.1 General Comments 120
4.1.2 Classification of Cancer 121
4.1.3 The Incidence and Mortality of Malignant Cancer 123
4.2 The Cellular Basis of Cancer 125
4.2.1 Carcinogenesis 125
4.2.2 Genes, Proto-oncogenes and Oncogenes 125
4.2.3 Genes and Cancer 127
4.2.4 Developing Initiatives in Cancer Genetics 130
4.2.5 Summary of Section 4.2 132
4.3 Lung Cancer 133
4.3.1 Introduction 133
4.3.2 Molecular Pathology 134
4.3.3 Which Genes to Test? 136
4.3.4 Molecular Pathology Directing Treatment 138
4.4 Colorectal Cancer 140
4.4.1 Introduction 140
4.4.2 Molecular Pathology 141
4.4.3 Which Genes to Test? 143
4.4.4 Molecular Pathology Directing Treatment 143
4.5 Prostate Cancer 144
4.5.1 Introduction 144
4.5.2 Molecular Pathology 145
4.5.3 Which Genes to Test? 146
4.5.4 Molecular Pathology Directing Treatment 146
4.6 Breast Cancer 147
4.6.1 Introduction 147
4.6.2 Molecular Pathology 148
4.6.3 Which Genes to Test? 149
4.6.4 Molecular Pathology Directing Treatment 151
4.7 Pancreatic Cancer 154
4.7.1 Introduction 154
4.7.2 Molecular Pathology 154
4.7.3 Which Genes to Test? 155
4.7.4 Molecular Pathology Directing Treatment 156
4.8 Other Carcinomas 156
4.8.1 Oesophageal Cancer 156
4.8.2 Liver Cancer 156
4.8.3 Bladder Cancer 157
4.8.4 Renal Cancer 157
4.8.5 Ovarian Cancer 158
4.8.6 Rare Carcinomas 159
4.9 Chapter Summary 161
4.9.1 Ntrk 162
4.9.2 Brca 162
4.9.3 Panels of Genes 164
4.9.4 Bridge to Chapter 5 165
5 Solid Organ Cancers Part 2: Sarcoma, Neurological, Paediatric, Dermal and
Others 167
5.1 Sarcomas 168
5.1.1 Tumours Based on Bone 168
5.1.2 Tumours Based on Muscle and Soft Tissues 169
5.2 Tumours of the Central Nervous System 174
5.2.1 Gliomas 174
5.2.2 Meningiomas 177
5.2.3 Medulloblastomas 177
5.2.4 Pituitary Tumours 178
5.3 Paediatric Cancers 178
5.3.1 Introduction to Paediatrics 178
5.3.2 Blood Cancer 182
5.3.3 Neurological Tumours 186
5.3.4 Solid Organ Cancers 190
5.4 Dermal Cancers 194
5.4.1 Squamous Cell Carcinoma and Basal Cell Carcinoma 194
5.4.2 Melanoma 194
5.4.3 Dermatofibrosarcoma Protuberans 195
5.5 Other Cancers 196
5.5.1 Multiple Endocrine Neoplasia 196
5.5.2 Inherited Cancers 197
5.6 Summary 198
6 Blood Cancer 201
6.1 Lymphoma 202
6.1.1 Hodgkin Lymphoma 203
6.1.2 Non-Hodgkin Lymphoma 205
6.2 Leukaemia 211
6.2.1 The Aetiology of Leukaemia 212
6.2.2 Myeloid Leukaemia 213
6.2.3 Lymphoid Leukaemia 221
6.2.4 Other Types of Leukaemia 228
6.2.5 Measurable Residual Disease 232
6.3 Myeloma and Related Diseases 233
6.3.1 The Laboratory 233
6.3.2 Monoclonal Gammopathy of Undetermined Significance 234
6.3.3 Smouldering Multiple Myeloma 235
6.3.4 Myeloma 237
6.3.5 Plasma Cell Leukaemia 240
6.3.6 The Genetics of Disease Progression 241
6.3.7 Routine Molecular Pathology 241
6.4 Other Blood Cancer 242
6.4.1 Myelofibrosis 243
6.4.2 Polycythaemia Vera 244
6.4.3 Essential Thrombocythaemia 245
6.4.4 Myelodysplasia 246
6.4.5 Routine Molecular Pathology of MPNs 247
6.4.6 Erythroleukaemia 249
6.4.7 Basophils and Mast Cells 250
6.4.8 Histiocytosis 252
6.5 Summary 253
7 Rare, Inherited, Metabolic and Other Diseases 257
7.1 Cardiology 259
7.1.1 Structural Heart Disease 260
7.1.2 Arrhythmia 262
7.2 Developmental Disorders 264
7.3 Endocrinology 266
7.3.1 Diabetes 266
7.3.2 Thyroid 267
7.3.3 Adrenals 268
7.3.4 Parathyroids 269
7.3.5 Reproduction 270
7.3.6 The Pituitary/Hypothalamus 272
7.4 Ophthalmology and Audiology 273
7.4.1 Cataracts 273
7.4.2 Albinism 274
7.4.3 The Optic Nerve 275
7.4.4 Other Ocular Diseases 275
7.4.5 Audiology 276
7.5 Foetal and Non-invasive Prenatal Detection 277
7.5.1 The Foetus and Neonate 277
7.5.2 The Parent and Adult 278
7.6 Gastrohepatology 281
7.6.1 Porphyria 281
7.6.2 Cholestasis 281
7.6.3 Polycystic Liver Diseases 281
7.6.4 Pancreatitis 282
7.6.5 Hirschsprung Disease 282
7.7 Haematology 282
7.7.1 Haemoglobinopathies 283
7.7.2 Red Cell Enzymopathies 288
7.7.3 Combined Haemoglobinopathies and Enzymopathies 289
7.7.4 The Red Cell Membrane 290
7.7.5 Other Forms of Anaemia 290
7.7.6 Haemorrhagic Diseases 292
7.7.7 Thrombotic Diseases 295
7.7.8 Iron Metabolism 297
7.8 Immunology 298
7.8.1 Severe Combined Immunodeficiency 298
7.8.2 The Haemophagocytic Syndromes 298
7.8.3 Hereditary Angioedema 298
7.8.4 Other Immunological Diseases 299
7.9 Lipid and Metabolic Diseases 299
7.9.1 Lipids 299
7.9.2 Metabolic Diseases 300
7.10 Mitochondrial Diseases 305
7.11 Musculoskeletal Diseases 307
7.11.1 Diseases Linked to the Fibroblast Growth Factor Receptor 307
7.11.2 Muscular Dystrophy 308
7.11.3 Other Genetic Musculoskeletal Diseases 308
7.12 Neurological Diseases 309
7.12.1 Diseases of the Nerves 310
7.12.2 The Central Nervous System 311
7.12.3 Myopathy 313
7.13 Renal Diseases 314
7.13.1 The Leading Causes 314
7.13.2 Diseases Linked to Electrolyte Disturbances 315
7.13.3 Other Causes 316
7.14 Respiratory Diseases 316
7.14.1 Cystic Fibrosis 316
7.14.2 Other Respiratory Diseases 317
7.15 Dermatological Diseases 318
7.15.1 Xeroderma Pigmentosum 318
7.15.2 Other Dermatological Diseases 319
7.16 Summary 320
Genes Index 323
Text Index 345
Acknowledgements xvii
1 Introduction to Molecular Pathology 1
1.1 A Historical Perspective 2
1.1.1 The Development of Molecular Genetics 2
1.1.2 The Development of Molecular Pathology 8
1.2 The Scope of Human Disease 15
1.2.1 The Classification of Disease 15
1.2.2 Morbidity and Mortality 17
1.3 Chromosomal Abnormalities and Disease 19
1.3.1 Chromosomes in Health and Disease 19
1.3.2 Errors of Chromosome Numbers 24
1.3.3 Errors of Sections of Chromosomes 26
1.3.4 Micro-changes to the Genome 32
1.4 The Practice of Molecular Pathology 34
1.4.1 Personalised Medicine 35
1.4.2 National Developments in Molecular Pathology 36
1.4.3 A Move Back to the General Hospital 38
1.5 Conclusion and a View Forwards 39
2 Methods in Molecular Pathology 1 45
2.1 Sample Acquisition and Preparation 46
2.1.1 General Considerations 46
2.1.2 Blood and Soft Tissue 47
2.1.3 Tissues from Solid Organs 48
2.2 Cytogenetics and Karyotyping 49
2.2.1 Practical Considerations 49
2.2.2 Historical Perspective 50
2.2.3 Modern Clinical Applications 52
2.2.4 Paediatrics and Cytogenetics 54
2.3 Fluorescence In situ Hybridisation 54
2.3.1 The Evolution of FISH 55
2.3.2 Uses of FISH Variants in Pathology 56
2.3.3 Developments in FISH 61
2.4 Preparation of Nucleic Acids for Analysis 62
2.4.1 Obtaining DNA 62
2.4.2 Obtaining RNA 63
2.4.3 The Library 65
2.4.4 Amplification of DNA: The Polymerase Chain Reaction 66
2.4.5 Developments in PCR 68
2.5 DNA Sequencing 75
2.5.1 Sanger Sequencing 76
2.5.2 Technical Advances 77
2.5.3 The Human Genome Project 78
2.6 Microarrays 78
2.6.1 The Theory 78
2.6.2 The Practice 80
2.6.3 Disease-linked Gene Panels 83
2.7 Summary of First-generation Techniques 84
2.7.1 Moving On 85
3 Methods in Molecular Pathology 2 87
3.1 Next-generation Sequencing 88
3.1.1 Read Length 88
3.1.2 Pyrosequencing 89
3.1.3 Ion Torrent Technology 92
3.1.4 Illumina Sequencing 94
3.1.5 SOLiD Technology 97
3.1.6 Luminex Multi-analyte Profiling (xMAP) technology 99
3.1.7 RNA Sequencing 100
3.1.8 Wider Applications of Next-generation Sequencing 100
3.1.9 Global and Other Perspectives 104
3.2 Third-generation Sequencing 107
3.2.1 Nanopore Sequencing 108
3.2.2 Pacific Biosystems 110
3.2.3 DNA Nanoball Technology 112
3.3 Bioinformatics 114
3.4 Chapter Summary and Conclusions 115
3.4.1 The Technology 115
3.4.2 The Practice of Molecular Pathology 115
4 Solid Tumour Cancer 1: Carcinoma 119
4.1 Introduction to Cancer 120
4.1.1 General Comments 120
4.1.2 Classification of Cancer 121
4.1.3 The Incidence and Mortality of Malignant Cancer 123
4.2 The Cellular Basis of Cancer 125
4.2.1 Carcinogenesis 125
4.2.2 Genes, Proto-oncogenes and Oncogenes 125
4.2.3 Genes and Cancer 127
4.2.4 Developing Initiatives in Cancer Genetics 130
4.2.5 Summary of Section 4.2 132
4.3 Lung Cancer 133
4.3.1 Introduction 133
4.3.2 Molecular Pathology 134
4.3.3 Which Genes to Test? 136
4.3.4 Molecular Pathology Directing Treatment 138
4.4 Colorectal Cancer 140
4.4.1 Introduction 140
4.4.2 Molecular Pathology 141
4.4.3 Which Genes to Test? 143
4.4.4 Molecular Pathology Directing Treatment 143
4.5 Prostate Cancer 144
4.5.1 Introduction 144
4.5.2 Molecular Pathology 145
4.5.3 Which Genes to Test? 146
4.5.4 Molecular Pathology Directing Treatment 146
4.6 Breast Cancer 147
4.6.1 Introduction 147
4.6.2 Molecular Pathology 148
4.6.3 Which Genes to Test? 149
4.6.4 Molecular Pathology Directing Treatment 151
4.7 Pancreatic Cancer 154
4.7.1 Introduction 154
4.7.2 Molecular Pathology 154
4.7.3 Which Genes to Test? 155
4.7.4 Molecular Pathology Directing Treatment 156
4.8 Other Carcinomas 156
4.8.1 Oesophageal Cancer 156
4.8.2 Liver Cancer 156
4.8.3 Bladder Cancer 157
4.8.4 Renal Cancer 157
4.8.5 Ovarian Cancer 158
4.8.6 Rare Carcinomas 159
4.9 Chapter Summary 161
4.9.1 Ntrk 162
4.9.2 Brca 162
4.9.3 Panels of Genes 164
4.9.4 Bridge to Chapter 5 165
5 Solid Organ Cancers Part 2: Sarcoma, Neurological, Paediatric, Dermal and
Others 167
5.1 Sarcomas 168
5.1.1 Tumours Based on Bone 168
5.1.2 Tumours Based on Muscle and Soft Tissues 169
5.2 Tumours of the Central Nervous System 174
5.2.1 Gliomas 174
5.2.2 Meningiomas 177
5.2.3 Medulloblastomas 177
5.2.4 Pituitary Tumours 178
5.3 Paediatric Cancers 178
5.3.1 Introduction to Paediatrics 178
5.3.2 Blood Cancer 182
5.3.3 Neurological Tumours 186
5.3.4 Solid Organ Cancers 190
5.4 Dermal Cancers 194
5.4.1 Squamous Cell Carcinoma and Basal Cell Carcinoma 194
5.4.2 Melanoma 194
5.4.3 Dermatofibrosarcoma Protuberans 195
5.5 Other Cancers 196
5.5.1 Multiple Endocrine Neoplasia 196
5.5.2 Inherited Cancers 197
5.6 Summary 198
6 Blood Cancer 201
6.1 Lymphoma 202
6.1.1 Hodgkin Lymphoma 203
6.1.2 Non-Hodgkin Lymphoma 205
6.2 Leukaemia 211
6.2.1 The Aetiology of Leukaemia 212
6.2.2 Myeloid Leukaemia 213
6.2.3 Lymphoid Leukaemia 221
6.2.4 Other Types of Leukaemia 228
6.2.5 Measurable Residual Disease 232
6.3 Myeloma and Related Diseases 233
6.3.1 The Laboratory 233
6.3.2 Monoclonal Gammopathy of Undetermined Significance 234
6.3.3 Smouldering Multiple Myeloma 235
6.3.4 Myeloma 237
6.3.5 Plasma Cell Leukaemia 240
6.3.6 The Genetics of Disease Progression 241
6.3.7 Routine Molecular Pathology 241
6.4 Other Blood Cancer 242
6.4.1 Myelofibrosis 243
6.4.2 Polycythaemia Vera 244
6.4.3 Essential Thrombocythaemia 245
6.4.4 Myelodysplasia 246
6.4.5 Routine Molecular Pathology of MPNs 247
6.4.6 Erythroleukaemia 249
6.4.7 Basophils and Mast Cells 250
6.4.8 Histiocytosis 252
6.5 Summary 253
7 Rare, Inherited, Metabolic and Other Diseases 257
7.1 Cardiology 259
7.1.1 Structural Heart Disease 260
7.1.2 Arrhythmia 262
7.2 Developmental Disorders 264
7.3 Endocrinology 266
7.3.1 Diabetes 266
7.3.2 Thyroid 267
7.3.3 Adrenals 268
7.3.4 Parathyroids 269
7.3.5 Reproduction 270
7.3.6 The Pituitary/Hypothalamus 272
7.4 Ophthalmology and Audiology 273
7.4.1 Cataracts 273
7.4.2 Albinism 274
7.4.3 The Optic Nerve 275
7.4.4 Other Ocular Diseases 275
7.4.5 Audiology 276
7.5 Foetal and Non-invasive Prenatal Detection 277
7.5.1 The Foetus and Neonate 277
7.5.2 The Parent and Adult 278
7.6 Gastrohepatology 281
7.6.1 Porphyria 281
7.6.2 Cholestasis 281
7.6.3 Polycystic Liver Diseases 281
7.6.4 Pancreatitis 282
7.6.5 Hirschsprung Disease 282
7.7 Haematology 282
7.7.1 Haemoglobinopathies 283
7.7.2 Red Cell Enzymopathies 288
7.7.3 Combined Haemoglobinopathies and Enzymopathies 289
7.7.4 The Red Cell Membrane 290
7.7.5 Other Forms of Anaemia 290
7.7.6 Haemorrhagic Diseases 292
7.7.7 Thrombotic Diseases 295
7.7.8 Iron Metabolism 297
7.8 Immunology 298
7.8.1 Severe Combined Immunodeficiency 298
7.8.2 The Haemophagocytic Syndromes 298
7.8.3 Hereditary Angioedema 298
7.8.4 Other Immunological Diseases 299
7.9 Lipid and Metabolic Diseases 299
7.9.1 Lipids 299
7.9.2 Metabolic Diseases 300
7.10 Mitochondrial Diseases 305
7.11 Musculoskeletal Diseases 307
7.11.1 Diseases Linked to the Fibroblast Growth Factor Receptor 307
7.11.2 Muscular Dystrophy 308
7.11.3 Other Genetic Musculoskeletal Diseases 308
7.12 Neurological Diseases 309
7.12.1 Diseases of the Nerves 310
7.12.2 The Central Nervous System 311
7.12.3 Myopathy 313
7.13 Renal Diseases 314
7.13.1 The Leading Causes 314
7.13.2 Diseases Linked to Electrolyte Disturbances 315
7.13.3 Other Causes 316
7.14 Respiratory Diseases 316
7.14.1 Cystic Fibrosis 316
7.14.2 Other Respiratory Diseases 317
7.15 Dermatological Diseases 318
7.15.1 Xeroderma Pigmentosum 318
7.15.2 Other Dermatological Diseases 319
7.16 Summary 320
Genes Index 323
Text Index 345